NCT07287995 2026-03-16A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsAstellas Pharma IncPhase 1/2 Recruiting428 enrolled
NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT04452214 2023-07-14A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid TumorsCantargia ABPhase 1 Completed19 enrolled
NCT01478685 2019-11-12A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCelgenePhase 1 Completed169 enrolled